US Drug Recall Register
Class I · High risk Terminated Initiated Apr 19, 2013 (13 years ago)

Lidocaine 18.18 mg/mL/Bupivacaine 2.27 mg/mL/Epinephrine 0.0022…

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Non-Sterility

What was recalled

Lidocaine 18.18 mg/mL/Bupivacaine 2.27 mg/mL/Epinephrine 0.0022 mg/mL/Hyaluronidase13.64 u/mL, supplied in 11 mL Sterile Syringes, Rx only, Compounded med, Single use only, (Red Block) ABRAMS ROYAL Compounding Pharmacy, Dallas, TX

Recalling firm
Abrams Royal Pharmacy
Origin
TX, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0251-2015

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Lidocaine recalls

See all
Class II · Moderate risk Ongoing

Xylocaine

Reason Presence of Particulate Matter: Hair was found in products

Fresenius Kabi USA, LLC D-0729-2026
Class II · Moderate risk Ongoing

Xylocaine

Reason Presence of Particulate Matter: Hair was found in products

Fresenius Kabi USA, LLC D-0728-2026
Class II · Moderate risk Ongoing

Lidocaine HCl Injection

Reason Presence of Particulate Matter: Hair was found in products

Fresenius Kabi USA, LLC D-0726-2026
Class III · Low risk Ongoing

Lidolog Kit

Reason Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan

Asclemed USA Inc. D-0713-2026
Class II · Moderate risk Ongoing

Lidocaine HCl Injection USP

Reason Lack of Assurance of Sterility

Asclemed USA Inc. D-0659-2026